Regular visits to a diabetes clinic were associated with lower magnitude of visual disability and diabetic retinopathy - A hospital-based historical cohort study in Yemen

Diabetes Technology and Therapeutics

Volumn 11, Issue 1, 2009, Pages 45-50

  Bamashmus, Mahfouth A ^a,b   Gunaid, Abdallah A ^a   Khandekar, Rajiv ^c,d  

^a SANA A UNIVERSITY   (Yemen)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Yemen)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Eye and Ear Health Care Muscat   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; COMORBIDITY; DIABETES MELLITUS; DIABETIC CLINIC VISIT; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EYE DISEASE; EYE EXAMINATION; FEMALE; HEALTH CARE; HUMAN; HYPERTENSION; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VISUAL ACUITY; VISUAL DISORDER; YEMEN;

ADULT; AGE OF ONSET; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK; SEVERITY OF ILLNESS INDEX; VISION DISORDERS; YEMEN;

EID: 58149392691     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2007.0299     Document Type: Article

References (23)

1. Implementation of VISION 2020 in the Eastern Mediterranean Region - Report on a Planning Workshop: Cairo, Egypt, 14-17 December 2003. Publication WHO-EM/ CPB/001/E. Nasr City, Egypt: World Health Organization Regional Office for the Eastern Mediterranean, 2004.
2. World Health Organization: Prevention of Blindness from Diabetes Mellitus. Report of a WHO Consultation. Geneva: World Health Organization, 2006:1-3.
3. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, De-Cristofaro A, Kerr EA: The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-2645.
4. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569.
5. Higgins GT, Khan J, Pearce IA: Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies? Acta Ophthalmol Scand 2007;85:772-776.
6. Bressler SB, Bressler NM: Retinopathy in patients with type 1 diabetes 4 years after intensive therapy. Arch Ophthalmol 2000;118:984-985.
7. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 1995;102:647-661.
8. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Publication Number WHO/NCD/NCS/99.2. Geneva: World Health Organization, 1999.
9. Zanchetti A: Clinical practice and guidelines in Europe for the treatment of hypertension, with a focus on patients with diabetes mellitus. Clin Ther 2007;29(Suppl B):S44-S53.
10. rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-1682.
11. nd, Bower KS: Evaluation of digital fundus images as a diagnostic method for surveillance of diabetic retinopathy. Mil Med 2007;172:405-410.
12. Tuladhar H, Dali SM, Pradhanang V: Complications of home delivery: a retrospective analysis. JNMA J Nepal Med Assoc 2005;44:87-91.
13. Al-Till MI, Al-Bdour MD, Ajlouni KM: Prevalence of blindness and visual impairment among Jordanian diabetics. Eur J Ophthalmol 2005;15:62-68.
14. Ismail AI, Sohn W: The impact of universal access to dental care on disparities in caries experience in children. J Am Dent Assoc 2001;132:295-303.
15. Khandekar R, Al Lawatii J, Mohammed AJ, Al Raisi A: Diabetic retinopathy in Oman: a hospital based study. Br J Ophthalmol 2003;87:1061-1064.
16. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM, Narayan KM: Diabetes and physical disability among older U.S. adults. Diabetes Care 2000;23:1272-1277.
17. Maty SC, Fried LP, Volpato S, Williamson J, Brancati FL, Blaum CS: Patterns of disability related to diabetes mellitus in older women. J Gerontol A Biol Sci Med Sci 2004;59:148-153.
18. Khandekar R, Mohammed AJ: Visual disabilities among diabetics in Oman. Saudi Med J 2005;26:836-841.
19. Centers for Disease Control and Prevention (CDC): Prevalence of visual impairment and selected eye diseases among persons aged ≥50 years with and without diabetes - United States, 2002. MMWR Morb Mortal Wkly Rep 2004;53:1069-1071.
20. Klauss V, Schaller UC: International initiatives for the prevention of blindness [in German]. Ophthalmologe 2007;104:855-859.
21. Taylor RH, Jones HS, Dodson PM, Hamilton AP, Kritzinger EE: Diabetic eye disease: a natural history study. Eye 1997;11:547-553.
22. Oxman AD, Lavis JN, Fretheim A: Use of evidence in WHO recommendations. Lancet 2007;369:1883-1889.
23. Al-Maskari F, El-Sadig M: Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol 2007;7:11.